CHEBI:47780 - clomipramine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name clomipramine
ChEBI ID CHEBI:47780
Definition A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:47359, CHEBI:3754
Supplier Information ChemicalBook:CB5173107, eMolecules:1883437, ZINC000000020248
Download Molfile XML SDF
more structures >>
Wikipedia License
Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). It is used in the treatment of various conditions, most notably obsessive–compulsive disorder but also many other disorders, including hyperacusis, panic disorder, major depressive disorder, trichotillomania, body dysmorphic disorder and chronic pain. It has also been notably used to treat premature ejaculation and the cataplexy associated with narcolepsy. It may also address certain fundamental features surrounding narcolepsy besides cataplexy (especially hypnagogic and hypnopompic hallucinations). The evidence behind this, however, is less robust. As with other antidepressants (notably including selective serotonin reuptake inhibitors), it may paradoxically increase the risk of suicide in those under the age of 25, at least in the first few weeks of treatment. It is typically taken by mouth, although intravenous preparations are sometimes used. Common side effects include dry mouth, constipation, loss of appetite, sleepiness, weight gain, sexual dysfunction, and trouble urinating. Serious side effects include an increased risk of suicidal behavior in those under the age of 25, seizures, mania, and liver problems. If stopped suddenly, a withdrawal syndrome may occur with headaches, sweating, and dizziness. It is unclear if it is safe for use in pregnancy. Its mechanism of action is not entirely clear but is believed to involve increased levels of serotonin and norepinephrine. Clomipramine was discovered in 1964 by the Swiss drug manufacturer Ciba-Geigy. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication.
Read full article at Wikipedia
Formula C19H23ClN2
Net Charge 0
Average Mass 314.85210
Monoisotopic Mass 314.15498
InChI InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3
InChIKey GDLIGKIOYRNHDA-UHFFFAOYSA-N
SMILES CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12
Roles Classification
Biological Role(s): serotonin uptake inhibitor
A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.
anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
serotonergic antagonist
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
serotonergic drug

EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of trypanothione-disulfide reductase (EC 1.8.1.12).
Application(s): serotonin uptake inhibitor
A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
serotonergic antagonist
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
serotonergic drug

View more via ChEBI Ontology
ChEBI Ontology
Outgoing clomipramine (CHEBI:47780) has functional parent imipramine (CHEBI:47499)
clomipramine (CHEBI:47780) has role anticoronaviral agent (CHEBI:149553)
clomipramine (CHEBI:47780) has role antidepressant (CHEBI:35469)
clomipramine (CHEBI:47780) has role EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor (CHEBI:77402)
clomipramine (CHEBI:47780) has role serotonergic antagonist (CHEBI:48279)
clomipramine (CHEBI:47780) has role serotonergic drug (CHEBI:48278)
clomipramine (CHEBI:47780) has role serotonin uptake inhibitor (CHEBI:50949)
clomipramine (CHEBI:47780) is a dibenzoazepine (CHEBI:47804)
clomipramine (CHEBI:47780) is conjugate base of clomipramine(1+) (CHEBI:64209)
Incoming clomipramine(1+) (CHEBI:64209) is conjugate acid of clomipramine (CHEBI:47780)
IUPAC Name
3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
Synonyms Sources
3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine NIST Chemistry WebBook
3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE PDBeChem
3-chloroimipramine ChemIDplus
chlorimipramine NIST Chemistry WebBook
Clomipramine KEGG COMPOUND
G 34586 NIST Chemistry WebBook
monochlorimipramine NIST Chemistry WebBook
Manual Xrefs Databases
701 DrugCentral
C06918 KEGG COMPOUND
CH371799 Patent
Clomipramine Wikipedia
CXX PDBeChem
D07727 KEGG DRUG
DB01242 DrugBank
LSM-3171 LINCS
US3467650 Patent
View more database links
Registry Numbers Types Sources
1323477 Reaxys Registry Number Reaxys
303-49-1 CAS Registry Number KEGG COMPOUND
303-49-1 CAS Registry Number ChemIDplus
303-49-1 CAS Registry Number NIST Chemistry WebBook
Citations
Jones DC, Ariza A, Chow WH, Oza SL, Fairlamb AH (2010)
Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.
Molecular and biochemical parasitology 169, 12-19 [PubMed:19747949]
[show Abstract]
Gillman PK (2007)
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated.
British journal of pharmacology 151, 737-748 [PubMed:17471183]
[show Abstract]
Rivarola HW, Bustamante JM, Lo Presti S, Fernández AR, Enders JE, Gea S, Fretes R, Paglini-Oliva P (2005)
Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area.
Experimental parasitology 111, 80-86 [PubMed:16085036]
[show Abstract]
Ivey JL, Rosenberg DR (2002)
Clomipramine use in obsessive-compulsive disorder.
Expert review of neurotherapeutics 2, 783-790 [PubMed:19810911]
[show Abstract]
Pirola R, Mundo E, Bellodi L, Bareggi SR (2002)
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 772, 205-210 [PubMed:12007764]
[show Abstract]
Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN (2002)
Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
Schizophrenia research 56, 11-17 [PubMed:12084414]
[show Abstract]
Last Modified
23 April 2020